On the importance of population-based serological surveys of SARS-CoV-2 without overlooking their inherent uncertainties
- PMID: 34171042
- PMCID: PMC7242922
- DOI: 10.1016/j.puhip.2020.100013
On the importance of population-based serological surveys of SARS-CoV-2 without overlooking their inherent uncertainties
Abstract
The SARS-CoV-2 epidemic has caused an unprecedented public health situation and more than ever it is important to be well informed on methods to monitor and analyse the progression of the epidemic. This brief note aims to explain the scope in conducting large-scale serological surveys of SARS-CoV-2 to define the landscape of population immunity, without overlooking the inherent uncertainty steaming from sampling design and diagnostic validity. The note completes with a succinct appendix of simple statistical methods for estimating prevalence from random population samples using imperfect diagnostic tests.
Keywords: Antibodies; Coronavirus; Diagnostic validity; Random sampling; Seroepidemiology; Seroprevalence.
© 2020 The Author.
Conflict of interest statement
The author is an Editorial Board member of Public Health in Practice. The author declares that he has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.JAMA Netw Open. 2021 Jan 4;4(1):e2033706. doi: 10.1001/jamanetworkopen.2020.33706. JAMA Netw Open. 2021. PMID: 33399860 Free PMC article.
-
The risk of over-diagnosis in serological testing. Implications for communications strategies.Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):184-192. doi: 10.19191/EP20.5-6.S2.117. Epidemiol Prev. 2020. PMID: 33412809 English.
-
Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies.Microbiol Spectr. 2022 Jun 29;10(3):e0247121. doi: 10.1128/spectrum.02471-21. Epub 2022 May 25. Microbiol Spectr. 2022. PMID: 35612315 Free PMC article.
-
Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications.Biochem Soc Trans. 2020 Dec 18;48(6):2851-2863. doi: 10.1042/BST20200744. Biochem Soc Trans. 2020. PMID: 33170924 Review.
-
Serological assays for emerging coronaviruses: challenges and pitfalls.Virus Res. 2014 Dec 19;194:175-83. doi: 10.1016/j.virusres.2014.03.018. Epub 2014 Mar 23. Virus Res. 2014. PMID: 24670324 Free PMC article. Review.
Cited by
-
Severe acute respiratory syndrome coronavirus 2 antibody seroprevalence in Lebanon: a population-based cross-sectional study.IJID Reg. 2022 Mar;2:184-190. doi: 10.1016/j.ijregi.2022.01.011. Epub 2022 Jan 29. IJID Reg. 2022. PMID: 35721422 Free PMC article.
-
Socio-economic determinants of SARS-CoV-2 infection: Results from a population-based cross-sectional serosurvey in Geneva, Switzerland.Front Public Health. 2022 Sep 23;10:874252. doi: 10.3389/fpubh.2022.874252. eCollection 2022. Front Public Health. 2022. PMID: 36211707 Free PMC article.
-
SARS-CoV-2 Seroepidemiology and Antibody Levels in Children during BA.5 Predominance Period.Diagnostics (Basel). 2024 May 17;14(10):1039. doi: 10.3390/diagnostics14101039. Diagnostics (Basel). 2024. PMID: 38786337 Free PMC article.
-
SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance.Epidemiol Infect. 2022 Oct 19;150:e177. doi: 10.1017/S0950268822001601. Epidemiol Infect. 2022. PMID: 36345855 Free PMC article.
-
High Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence After the Third Epidemic Wave (May-October 2021) in Matadi, Democratic Republic of the Congo.Open Forum Infect Dis. 2023 Jan 18;10(1):ofad023. doi: 10.1093/ofid/ofad023. eCollection 2023 Jan. Open Forum Infect Dis. 2023. PMID: 36726537 Free PMC article.
References
-
- Cairns E. Covid-19 antibody tests face a very specific problem. Evaluate Vantage. 2020
LinkOut - more resources
Full Text Sources
Miscellaneous